首页> PloS one> Epigenetic Activity of Peroxisome Proliferator-Activated Receptor Gamma Agonists Increases the Anticancer Effect of Histone Deacetylase Inhibitors on Multiple Myeloma Cells.

Epigenetic Activity of Peroxisome Proliferator-Activated Receptor Gamma Agonists Increases the Anticancer Effect of Histone Deacetylase Inhibitors on Multiple Myeloma Cells.

导出 OA

翻译打印收藏纠错

第一作者： Nassera,Aouali

第一单位： Laboratory of Experimental Hemato-Oncology, LHCE, Luxembourg Institute of Health (LIH), Strassen, Luxembourg.

作者： Nassera,Aouali ^[1] ; Angeliki,Broukou ^[1] ; Manon,Bosseler ^[1] ; Olivier,Keunen ^[2] ; Vincent,Schlesser ^[3] ; Bassam,Janji ^[1] ; Valerie,Palissot ^[1] ; Philippe,Stordeur ^[4] ; Guy,Berchem ^[5]

作者单位： Laboratory of Experimental Hemato-Oncology, LHCE, Luxembourg Institute of Health (LIH), Strassen, Luxembourg. ^[1] Laboratory Neuro-Oncology, Norlux, Luxembourg Institute of Health (LIH), Strassen, Luxembourg. ^[2] Laboratory of Hematology, Centre Hospitalier de Luxembourg (CHL), Strassen, Luxembourg. ^[3] Biotechnology Department, Experimental Infectious Diseases Platform, CER Group, Marloie, Belgium. ^[4] Laboratory of Experimental Hemato-Oncology, LHCE, Luxembourg Institute of Health (LIH), Strassen, Luxembourg; Laboratory of Hematology, Centre Hospitalier de Luxembourg (CHL), Strassen, Luxembourg. ^[5]